Placenta growth factor is not required for exercise-induced angiogenesis
- 1 January 2004
- journal article
- Published by Springer Nature in Angiogenesis
- Vol. 7 (3) , 277-284
- https://doi.org/10.1007/s10456-004-4179-1
Abstract
Angiogenesis is a tightly regulated process, both during development and adult life. Animal models with mutations in the genes coding for placental growth factor (PlGF), a member of vascular endothelial growth factor (VEGF) family, or the tyrosine kinase domain of the PlGF receptor (Flt-1) have revealed differences between normal physiological angiogenesis and pathological angiogenesis associated with conditions such as tumor growth, arthritis and atherosclerosis. In the present paper, we investigated the potential role of PlGF in regulating physiological angiogenesis by analyzing vascular changes in heart and skeletal muscles of wild-type and Plgf −/− mice following prolonged and sustained physical training. Sedentary Plgf −/− mice showed a reduced capillary density in both heart and skeletal muscles as compared to wild-type mice (P < 0.05). However, after a 6-week training period, heart/body weight ratio, citrate synthase activity, vessel density and capillary/myocyte ratio were significantly increased in both wild-type and Plgf −/− mice (all P < 0.05). At the same time intercapillary distance was significantly reduced. Finally, acute exercise was not associated with any change in PlGF protein level in the skeletal muscle. Our results demonstrate that PlGF is not necessary for exercise-training-induced angiogenesis. We thus suggest that the role of PlGF is confined to the selective regulation of angiogenesis only under pathological conditions.Keywords
This publication has 17 references indexed in Scilit:
- Angiogenic growth factor response to acute systemic exercise in human skeletal muscleJournal of Applied Physiology, 2004
- Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial DiseaseCirculation, 2003
- Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1Nature Medicine, 2003
- Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial IschemiaCirculation, 2003
- Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1Nature Medicine, 2002
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsNature Medicine, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Angiogenic growth factor mRNA responses in muscle to a single bout of exerciseJournal of Applied Physiology, 1996
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996